Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.55x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.55Latest market snapshot
Implied fair value · at BELFA's multiple
$8.0681.5% below market
12.37 SUPN revenue / share×0.65x BELFA P/S=$8.06
Market $43.55Implied $8.06
BELFA · current priceP/S 0.65x
$202.46Latest market snapshot
Implied fair value · at SUPN's multiple
$1,093.51440.1% above market
310.57 BELFA revenue / share×3.52x SUPN P/S=$1,093.51
Market $202.46Implied $1,093.51